Хайлтын үр дүнгүүд - Pieters, Rob
- 133-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
-
5
-
6
Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients -н Pieters, Rob, Huismans, Dieuwke R., Loonen, Anne H., Hählen, Karel, Veerman, Anjo J. P.
Хэвлэсэн 1991текст -
7
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia -н Buitenkamp, Trudy D., Mathôt, Ron A.A., de Haas, Valerie, Pieters, Rob, Zwaan, C. Michel
Хэвлэсэн 2010текст -
8
-
9
Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo -н Kerstjens, Mark, Pinhancos, Sandra S., Castro, Patricia Garrido, Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Хэвлэсэн 2018текст -
10
Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia -н Kerstjens, Mark, Garrido Castro, Patricia, Pinhanços, Sandra S., Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Хэвлэсэн 2021текст -
11
Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements -н Homminga, Irene, Vuerhard, Maartje J., Langerak, Anton W., Buijs-Gladdines, Jessica, Pieters, Rob, Meijerink, Jules P.P.
Хэвлэсэн 2012текст -
12
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations -н Kerstjens, Mark, Driessen, Emma M.C., Willekes, Merel, Pinhanços, Sandra S., Schneider, Pauline, Pieters, Rob, Stam, Ronald W.
Хэвлэсэн 2016текст -
13
-
14
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study -н van der Linde, Margrietha, van Leeuwen, Nikki, Eijkenaar, Frank, Rijneveld, Anita W., Pieters, Rob, Karim-Kos, Henrike E.
Хэвлэсэн 2022текст -
15
-
16
-
17
High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia -н Jerchel, Isabel S., Chatzivasileiou, Danai, Hoogkamer, Alex Q., Boer, Judith M., Beverloo, H. Berna, Pieters, Rob, den Boer, Monique L.
Хэвлэсэн 2018текст -
18
Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia -н van Atteveld, Jenneke E, de Winter, Demi TC, Pieters, Rob, Neggers, Sebastian JCMM, van den Heuvel-Eibrink, Marry M
Хэвлэсэн 2021текст -
19
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase -н Pieters, Rob, Hunger, Stephen P, Boos, Joachim, Rizzari, Carmelo, Silverman, Lewis, Baruchel, Andre, Goekbuget, Nicola, Schrappe, Martin, Pui, Ching-Hon
Хэвлэсэн 2010текст -
20
Alterations in Epithelial and Mesenchymal Intestinal Gene Expression During Doxorubicin-Induced Mucositis in Mice -н de Koning, Barbara A E, Lindenbergh-Kortleve, Dicky J., Pieters, Rob, Büller, Hans A., Renes, Ingrid B., Einerhand, Alexandra W. C.
Хэвлэсэн 2007текст